Cargando…
MIF-Dependent Control of Tumor Immunity
Initially identified as a T lymphocyte-elicited inhibitor of macrophage motility, macrophage migration inhibitory factor (MIF) has since been found to be expressed by nearly every immune cell type examined and overexpressed in most solid and hematogenous malignant cancers. It is localized to both ex...
Autores principales: | Noe, Jordan T., Mitchell, Robert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724107/ https://www.ncbi.nlm.nih.gov/pubmed/33324425 http://dx.doi.org/10.3389/fimmu.2020.609948 |
Ejemplares similares
-
Parasite-Produced MIF Cytokine: Role in Immune Evasion, Invasion, and Pathogenesis
por: Ghosh, Swagata, et al.
Publicado: (2019) -
MIF: Implications in the Pathoetiology of Systemic Lupus Erythematosus
por: Lang, Tali, et al.
Publicado: (2015) -
Arrest Functions of the MIF Ligand/Receptor Axes in Atherogenesis
por: Tillmann, Sabine, et al.
Publicado: (2013) -
Serum Levels of Migration Inhibitory Factor (MIF) and In Situ Expression of MIF and Its Receptor CD74 in Lepromatous Leprosy Patients: A Preliminary Report
por: Martinez-Guzman, Marco Alonso, et al.
Publicado: (2018) -
MIF and CXCL12 in Cardiovascular Diseases: Functional Differences and Similarities
por: van der Vorst, Emiel P. C., et al.
Publicado: (2015)